Vilya-2 predicts diverse molecular interfaces with high accuracy

Vilya-2 is a structure-prediction network that accurately models peptide therapeutics with non-canonical residues, enabling computational design of chemically diverse molecular interfaces. The model fills a gap where existing co-evolution-based methods fail for peptide drugs.